Breast cancer: Difference between revisions
Adeel Jamil (talk | contribs) |
|||
| Line 51: | Line 51: | ||
|MedCond =Carcinoma of the breast in male|Nandrolone}} | |MedCond =Carcinoma of the breast in male|Nandrolone}} | ||
{{MedCondContrAbs | {{MedCondContrAbs | ||
|MedCond =Carcinoma of the breast in females with hypercalcemia|Nandrolone}} | |MedCond =Carcinoma of the breast in females with hypercalcemia|Nandrolone|Hydroxyprogesterone caproate}} | ||
==[[Breast cancer primary prevention|Primary Prevention]]== | ==[[Breast cancer primary prevention|Primary Prevention]]== | ||
Revision as of 14:09, 2 April 2015
| Breast cancer | |
| ICD-10 | C50 |
|---|---|
| ICD-9 | 174-175 |
| OMIM | 114480 |
| DiseasesDB | 1598 |
| MedlinePlus | 000913 |
| MeSH | D001943 |
|
Breast Cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Breast cancer On the Web |
|
American Roentgen Ray Society Images of Breast cancer |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor(s)-In-Chief: Jack Khouri, Prashanth Saddala
Overview
Historical Perspective
Classification
Major Scheme | Staging | Pathologic Types | Histologic Types
Pathophysiology
Causes
Differentiating Breast Cancer from other Diseases
Epidemiology and Demographics
Risk factors
Screening
X Ray Mammography | Breast MRI | Breast Ultrasound | Self Exam | Genetic Testing
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Staging | Laboratory Findings | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Diagnostic Studies
Treatment
Chemotherapy | Bone Metastasis | Metastatic Breast Cancer Treatment | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Contraindicated medications
Breast carcinoma is considered an absolute contraindication to the use of the following medications:
- Conjugated estrogens/bazedoxifene
- Norethindrone acetate and Ethinyl estradiol
- Drospirenone and Ethinyl estradiol
- Norgestimate and Ethinyl estradiol
- Norgestrel and Ethinyl estradiol
- Progesterone
Carcinoma of the breast in male is considered an absolute contraindication to the use of the following medications:
Carcinoma of the breast in females with hypercalcemia is considered an absolute contraindication to the use of the following medications:
Primary Prevention
Phytoestrogens and Soy | Folic Acid (Folate) | Oophorectomy and Mastectomy | Medications
Case Studies
Related Chapters
- List of breast carcinogenic substances
- Breast reconstruction
- Alcohol and cancer
- Mammography Quality Standards Act
- National Comprehensive Cancer Network
- Breast Cancer Action
- Breakthrough Breast Cancer
- Barron Lerner (Physician)
- William Stewart Halsted (Radical Mastectomy)
- International Agency for Research on Cancer
- The Hormone Foundation
- Susan G. Komen for the Cure
External links
- Breast localisation and excision: Operation Script on Wikisurgery.
- Breast localisation and excision : Information for patients on Wikisurgery.
- Breast subareolar excision : Operation Script on Wikisurgery.
- Breast subareolar excision daycase : Information for patients on Wikisurgery.
- Breast wide excision: Operation Script on Wikisurgery.
- Breast wide excision: Information for patients on Wikisurgery.
- Fine needle aspiration: Operation Script on Wikisurgery.
- Mastectomy: Operation Script on Wikisurgery.
- Mastectomy: Information for patients on Wikisurgery.
- Mastectomy subcutaneous male daycase: Information for patients on Wikisurgery.
- Trucut needle biopsy: Operation Script on Wikisurgery.